Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 1.112% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. COc1cccc(CC(=O)N2CCCC(CCC(=O)N3CCN(c4ccccn4)CC3)C2)c1
b. CC(NC(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1)c1ccc(S(N)(=O)=O)cc1
Answer: b. CC(NC(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1)c1ccc(S(N)(=O)=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(NC(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1)c1ccc(S(N)(=O)=O)cc1
CC(NC(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1)c1ccc(S(N)(=O)=O)cc1
4-(phenylsulfamoyl)-N-[1-(4-sulfamoylphenyl)ethyl]benzamide